Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |